Skip to main content
. 2022 May 17;13:888660. doi: 10.3389/fphar.2022.888660

TABLE 4.

Mean peak and trough plasma rivaroxaban level in patients with or without bleeding events and recurrent ischaemic/thromboembolic events.

Occurrence of events Yes No p value
(mean ± SD)
Bleeding events Peak rivaroxaban level 278.2 ± 122.8 286.9 ± 123.6 1.00
Trough rivaroxaban level 59.9 ± 35.6 41.1 ± 29.2 0.011
Recurrent ischaemic/thrombotic events Peak rivaroxaban level 230.0 ± 120.0 287.6 ± 123.2 0.336
Trough rivaroxaban level 30.3 ± 14.8 47.6 ± 32.7 0.348